IBDEI0SL ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12867,1,3,0)
 ;;=3^HTN Retinopathy,OU
 ;;^UTILITY(U,$J,358.3,12867,1,4,0)
 ;;=4^H35.033
 ;;^UTILITY(U,$J,358.3,12867,2)
 ;;=^5005592
 ;;^UTILITY(U,$J,358.3,12868,0)
 ;;=H34.12^^51^623^17
 ;;^UTILITY(U,$J,358.3,12868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12868,1,3,0)
 ;;=3^CRAO,OS
 ;;^UTILITY(U,$J,358.3,12868,1,4,0)
 ;;=4^H34.12
 ;;^UTILITY(U,$J,358.3,12868,2)
 ;;=^5005558
 ;;^UTILITY(U,$J,358.3,12869,0)
 ;;=H34.11^^51^623^16
 ;;^UTILITY(U,$J,358.3,12869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12869,1,3,0)
 ;;=3^CRAO,OD
 ;;^UTILITY(U,$J,358.3,12869,1,4,0)
 ;;=4^H34.11
 ;;^UTILITY(U,$J,358.3,12869,2)
 ;;=^5005557
 ;;^UTILITY(U,$J,358.3,12870,0)
 ;;=H35.63^^51^623^27
 ;;^UTILITY(U,$J,358.3,12870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12870,1,3,0)
 ;;=3^Retinal HEMORRHAGE,OU
 ;;^UTILITY(U,$J,358.3,12870,1,4,0)
 ;;=4^H35.63
 ;;^UTILITY(U,$J,358.3,12870,2)
 ;;=^5005701
 ;;^UTILITY(U,$J,358.3,12871,0)
 ;;=H35.61^^51^623^25
 ;;^UTILITY(U,$J,358.3,12871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12871,1,3,0)
 ;;=3^Retinal HEMORRHAGE,OD
 ;;^UTILITY(U,$J,358.3,12871,1,4,0)
 ;;=4^H35.61
 ;;^UTILITY(U,$J,358.3,12871,2)
 ;;=^5005699
 ;;^UTILITY(U,$J,358.3,12872,0)
 ;;=H35.62^^51^623^26
 ;;^UTILITY(U,$J,358.3,12872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12872,1,3,0)
 ;;=3^Retinal HEMORRHAGE,OS
 ;;^UTILITY(U,$J,358.3,12872,1,4,0)
 ;;=4^H35.62
 ;;^UTILITY(U,$J,358.3,12872,2)
 ;;=^5005700
 ;;^UTILITY(U,$J,358.3,12873,0)
 ;;=H34.231^^51^623^18
 ;;^UTILITY(U,$J,358.3,12873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12873,1,3,0)
 ;;=3^Retinal Artery Branch Occlusion,OD
 ;;^UTILITY(U,$J,358.3,12873,1,4,0)
 ;;=4^H34.231
 ;;^UTILITY(U,$J,358.3,12873,2)
 ;;=^5005564
 ;;^UTILITY(U,$J,358.3,12874,0)
 ;;=H34.232^^51^623^19
 ;;^UTILITY(U,$J,358.3,12874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12874,1,3,0)
 ;;=3^Retinal Artery Branch Occulsion,OS
 ;;^UTILITY(U,$J,358.3,12874,1,4,0)
 ;;=4^H34.232
 ;;^UTILITY(U,$J,358.3,12874,2)
 ;;=^5005565
 ;;^UTILITY(U,$J,358.3,12875,0)
 ;;=H34.233^^51^623^20
 ;;^UTILITY(U,$J,358.3,12875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12875,1,3,0)
 ;;=3^Retinal Artery Branch Occlusion,OU
 ;;^UTILITY(U,$J,358.3,12875,1,4,0)
 ;;=4^H34.233
 ;;^UTILITY(U,$J,358.3,12875,2)
 ;;=^5005566
 ;;^UTILITY(U,$J,358.3,12876,0)
 ;;=H34.8310^^51^623^4
 ;;^UTILITY(U,$J,358.3,12876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12876,1,3,0)
 ;;=3^BRVO,OD w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,12876,1,4,0)
 ;;=4^H34.8310
 ;;^UTILITY(U,$J,358.3,12876,2)
 ;;=^5138488
 ;;^UTILITY(U,$J,358.3,12877,0)
 ;;=H34.8311^^51^623^5
 ;;^UTILITY(U,$J,358.3,12877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12877,1,3,0)
 ;;=3^BRVO,OD w/ Retinal Neovascularization
 ;;^UTILITY(U,$J,358.3,12877,1,4,0)
 ;;=4^H34.8311
 ;;^UTILITY(U,$J,358.3,12877,2)
 ;;=^5138489
 ;;^UTILITY(U,$J,358.3,12878,0)
 ;;=H34.8312^^51^623^6
 ;;^UTILITY(U,$J,358.3,12878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12878,1,3,0)
 ;;=3^BRVO,OD,Stable
 ;;^UTILITY(U,$J,358.3,12878,1,4,0)
 ;;=4^H34.8312
 ;;^UTILITY(U,$J,358.3,12878,2)
 ;;=^5138490
 ;;^UTILITY(U,$J,358.3,12879,0)
 ;;=H34.8320^^51^623^7
 ;;^UTILITY(U,$J,358.3,12879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12879,1,3,0)
 ;;=3^BRVO,OS w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,12879,1,4,0)
 ;;=4^H34.8320
 ;;^UTILITY(U,$J,358.3,12879,2)
 ;;=^5138491
